Evidence map›Paper›PMID 28128554›Full record

ArticleJournal of natural products2017

Discovery of C-Glycosylpyranonaphthoquinones in Streptomyces sp. MBT76 by a Combined NMR-Based Metabolomics and Bioinformatics Workflow.

Changsheng Wu, Chao Du, Koji Ichinose, Young Hae Choi, Gilles P van Wezel

Open access · hybridAbstract read
In one paragraph

Article in Journal of natural products, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Metabolic engineering ofEngineering microbiology · 2022
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Changsheng WuMolecular Biotechnology, Institute of Biology, Leiden University , Sylviusweg 72, 2333 BE Leiden, The Netherlands.
Chao DuMolecular Biotechnology, Institute of Biology, Leiden University , Sylviusweg 72, 2333 BE Leiden, The Netherlands.
Koji IchinoseResearch Institute of Pharmaceutical Sciences, Musashino University , Shinmachi, Nishitokyo-shi, Tokyo 202-8585, Japan.
Young Hae ChoiNatural Products Laboratory, Institute of Biology, Leiden University , Sylviusweg 72 2333 BE Leiden, The Netherlands.
Gilles P van WezelMolecular Biotechnology, Institute of Biology, Leiden University , Sylviusweg 72, 2333 BE Leiden, The Netherlands.ORCID 0000-0003-0341-1561
Leiden University · NLMusashino University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mining of microbial genomes has revealed that actinomycetes harbor far more biosynthetic potential for bioactive natural products than anticipated. Activation of (cryptic) biosynthetic gene clusters and identification of the corresponding metabolites has become a focal point for drug discovery. Here, we applied NMR-based metabolomics combined with bioinformatics to identify novel C-glycosylpyranonaphthoquinones in Streptomyces sp. MBT76 and to elucidate the biosynthetic pathway. Following activation of the cryptic qin gene cluster for a type II polyketide synthase (PKS) by constitutive expression of its pathway-specific activator, bioinformatics coupled to NMR profiling facilitated the chromatographic isolation and structural elucidation of qinimycins A-C (1-3). The intriguing structural features of the qinimycins, including 8-C-glycosylation, 5,14-epoxidation, and 13-hydroxylation, distinguished these molecules from the model pyranonaphthoquinones actinorhodin, medermycin, and granaticin. Another novelty lies in the unusual fusion of a deoxyaminosugar to the pyranonaphthoquinone backbone during biosynthesis of the antibiotics BE-54238 A and B (4, 5). Qinimycins showed weak antimicrobial activity against Gram-positive bacteria. Our work shows the utility of combining bioinformatics, targeted activation of cryptic gene clusters, and NMR-based metabolic profiling as an effective pipeline for the discovery of microbial natural products with distinctive skeletons.

Indexed as

ActinobacteriaAnti-Bacterial AgentsBacillus subtilisComputational BiologyEscherichia coliGlycosidesMetabolomicsMicrobial Sensitivity TestsMolecular StructureNaphthoquinonesNuclear Magnetic Resonance, BiomolecularPseudomonas aeruginosaPyrrolizidine AlkaloidsStaphylococcus aureusStreptomycesAnti-Bacterial AgentsBE 54238ABE 54238BGlycosidesNaphthoquinonesPyrrolizidine Alkaloids

Identifiers

PMID28128554
PMCPMC5373568
OpenAlexW2582479444

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.